Thrombolex, Inc. — Form D

Thrombolex, Inc. of Kingston, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2017-04-17. The offering totals $1.5M, of which $400K was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
John A CerminaroExecutive OfficerKingston, NJ
Marvin J WoodallDirectorKingston, NJ
Marvin J WoodallExecutive OfficerKingston, NJ
Kelly A ElliottDirectorKingston, NJ
Todd A RichmondDirectorKingston, NJ
Michael J CerminaroDirectorKingston, NJ
Michael J CerminaroExecutive OfficerKingston, NJ
Michael J CerminaroPromoterKingston, NJ
Tony J LitwillerExecutive OfficerKingston, NJ
Marvin WoodallDirectorRaleigh, NC
Marvin WoodallExecutive OfficerRaleigh, NC
Marvin WoodallPromoterRaleigh, NC
Paul A StewartDirectorMilwaukee, WI
Brian G FirthDirectorKingston, NJ
Brian G FirthExecutive OfficerKingston, NJ
John G CerminaroExecutive OfficerNew Britain, PA
David A. BonitaDirectorKingston, NJ
Keegan A. HarperDirectorKingston, NJ
Paul A. StewartDirectorKingston, NJ
Sam A. LiangDirectorKingston, NJ
Marvin J. WoodallDirectorKingston, NJ
Marvin J. WoodallExecutive OfficerKingston, NJ
John J. CerminaroExecutive OfficerKingston, NJ
Clay A. DeMarcusDirectorKingston, NJ
Michael J. CerminaroDirectorKingston, NJ

Other filings by this issuer (7)

FiledFormOfferingSold
2026-03-12D$51.1M$32.8M
2024-06-21D$5.0M$1.2M
2024-05-28D$4.8M$4.8M
2022-08-30D$2.0M$2.0M
2021-11-29D$5.0M$5.0M
2020-02-03D/A$9.8M
2018-04-17D/A$3.5M

More